Хайлтын үр дүнгүүд - Nadia Daizadeh
- 21-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosi... -н Elizabeth J. Samelson, Paul D. Miller, Claus Christiansen, Nadia Daizadeh, Luanda Grazette, Mary S. Anthony, Ogo Egbuna, Andrea Wang, Suresh Siddhanti, Angela M. Cheung, Nathalie Franchimont, Douglas P. Kiel
Хэвлэсэн 2013Artigo -
2
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab -н Heinz Wiendl, Matthew Carraro, Cristoforo Comi, Guillermo Izquierdo, Ho Jin Kim, Basil Sharrack, Carlo Tornatore, Nadia Daizadeh, Luke Chung, Alice K. Jacobs, Richard Hogan, Linda V. Wychowski, Bart Van Wijmeersch
Хэвлэсэн 2019Artigo -
3
Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study -н Sibyl Wray, Eva Havrdová, David R. Snydman, Douglas L. Arnold, Jeffrey Cohen, Alasdair Coles, Hans‐Peter Hartung, Krzysztof Selmaj, Howard L. Weiner, Nadia Daizadeh, David Margolin, Madalina Chirieac, D. A. S. Compston
Хэвлэсэн 2018Artigo -
4
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized pl... -н Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, Leda Mannent, Giorgio Walter Canonica, Joseph K. Han, Jorge Máspero, César Picado, Nadia Daizadeh, Benjamin Ortiz, Yongtao Li, Marcella Ruddy, Elizabeth Laws, Nikhil Amin
Хэвлэсэн 2021Artigo -
5
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures -н Emil H. Schemitsch, Theodore Miclau, Theofilos Karachalios, Lauren L. Nowak, Parag Sancheti, Rudolf W. Poolman, John Caminis, Nadia Daizadeh, Ricardo E. Dent-Acosta, Ogo Egbuna, Arkadi Chines, Judy Maddox, Andreas Grauer, Mohit Bhandari
Хэвлэсэн 2020Artigo -
6
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline -н Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira Lugogo, Philip G. Bardin, Martti Antila, David Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob‐Nara, Rebecca Gall, Yamo Deniz, Paul J. Rowe
Хэвлэсэн 2022Artigo -
7
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial -н Alasdair Coles, Douglas L. Arnold, Ann Bass, Aaron Boster, D. A. S. Compston, Óscar Fernández, Eva Havrdová, Kunio Nakamura, Anthony Traboulsee, Tjalf Ziemssen, Alice K. Jacobs, David Margolin, Xiaobi Huang, Nadia Daizadeh, Madalina Chirieac, Krzysztof Selmaj
Хэвлэсэн 2021Artigo -
8
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years -н Serge Ferrari, Jonathan D. Adachi, Kurt Lippuner, Carol Zapalowski, Paul D. Miller, Jean‐Yves Reginster, Ove Törring, David L. Kendler, Nadia Daizadeh, A. Wang, C. D. O’Malley, Rachel B. Wagman, Cesar Libanati, E. Michael Lewiecki
Хэвлэсэн 2015Artigo -
9
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223 -н Brian Steingo, Yaser Al Malik, Ann Bass, Regina Berkovich, Matthew Carraro, Óscar Fernández, Carolina Ionete, Luca Massacesi, Sven G. Meuth, Dimos D. Mitsikostas, Gabriel Pardo, Renata Simm, Anthony Traboulsee, Zia Choudhry, Nadia Daizadeh, D. A. S. Compston
Хэвлэсэн 2020Artigo -
10
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma -н Ian Pavord, Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Robert R. Johnson, Sivan Harel, Michel Djandji, Ledia Goga, Nora Crikelair, Paul J. Rowe, William W. Busse
Хэвлэсэн 2022Artigo -
11
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps -н Joaquim Mullol, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joseph K. Han, R. Jankowski, Jan Vodička, Philippe Gevaert, Nadia Daizadeh, Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent
Хэвлэсэн 2021Artigo -
12
Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma -н Nikolaos G. Papadopoulos, Stanley J. Szefler, Leonard B. Bacharier, Jorge Máspero, Christian Domingo, Alessandro Fiocchi, Jason K. Lee, Nadia Daizadeh, David J. Lederer, Megan Hardin, Rebecca Gall, Michel Djandji, Shahid Siddiqui, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe
Хэвлэсэн 2023Artigo -
13
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study -н Tjalf Ziemssen, Ann Bass, Regina Berkovich, Giancarlo Comi, Sara Eichau, Jeremy Hobart, Samuel F. Hunter, Christopher LaGanke, Volker Limmroth, Daniel Pelletier, Carlo Pozzilli, Sven Schippling, Lívia Sousa, Anthony Traboulsee, Bernard M.J. Uitdehaag, Bart Van Wijmeersch, Zia Choudhry, Nadia Daizadeh, B. Singer
Хэвлэсэн 2020Artigo -
14
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis -н Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan, Robert R. Johnson, Upender Kapoor, Faisal A. Khokhar, Nadia Daizadeh, Zhen Chen, Elizabeth Laws, Benjamin Ortiz, Juby A. Jacob‐Nara, Leda Mannent, Paul J. Rowe, Yamo Deniz
Хэвлэсэн 2022Artigo -
15
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years -н Jiwon Oh, Anat Achiron, Elisabeth Gulowsen Celius, Christina Chambers, Joy Derwenskus, Virginia Devonshire, Kerstin Hellwig, George J. Hutton, Pamela McCombe, Marie Moore, David Rog, Jean-Raphael Schneider, Renata Simm, Lívia Sousa, Stephen G. Vincent, Luke Chung, Nadia Daizadeh, Colin Mitchell, D. A. S. Compston
Хэвлэсэн 2020Artigo -
16
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma -н Ashish Bansal, Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Andrew Blauvelt, Marjolein de Bruin‐Weller, Jonathan Corren, Lawrence Sher, Emma Guttman‐Yassky, Zhen Chen, Nadia Daizadeh, Mohamed Kamal, Brad Shumel, Paola Mina‐Osorio, Leda Mannent, Naimish Patel, Neil M.H. Graham, Faisal A. Khokhar, Marius Ardeleanu
Хэвлэсэн 2021Artigo -
17
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study -н Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Celia J. F. Lin, David L. Kendler, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, P. Lakatos, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, A. Wang, Marc A. Gavin, Cesar Libanati, Rachel B. Wagman, Henry G. Bone
Хэвлэсэн 2015Artigo -
18
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases -н Giorgio Walter Canonica, Arnaud Bourdin, Anju T. Peters, Martin Desrosiers, Claus Bachert, Stephan Weidinger, Eric L. Simpson, Nadia Daizadeh, Zhen Chen, Siddhesh Kamat, Asif Khan, Jingdong Chao, Neil M.H. Graham, Elizabeth Laws, Ana B. Rossi, Marius Ardeleanu, Leda Mannent, Nikhil Amin, Benjamin Ortiz, Yamo Deniz, Michel Djandji, Paul J. Rowe
Хэвлэсэн 2022Artigo -
19
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction -н Nicola A. Hanania, Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald, Jorge Máspero, Constance H. Katelaris, Dave Singh, Nadia Daizadeh, Arman Altincatal, Nami Pandit‐Abid, Xavier Soler, Shahid Siddiqui, Elizabeth Laws, Juby A. Jacob‐Nara, Paul J. Rowe, David J. Lederer, Megan Hardin, Yamo Deniz
Хэвлэсэн 2022Artigo -
20
Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension -н Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati, Maria Luisa Brandi, Jacques P. Brown, E. J. Czerwiński, Marc-Antoine Krieg, Z. Man, Dan Mellström, S. Radominski, Jean‐Yves Reginster, Heinrich Resch, José Andrés Román Ivorra, Christian Roux, Eric Vittinghoff, Matthew Austin, Nadia Daizadeh, Michelle N. Bradley, Andreas Grauer, Steven R. Cummings, Henry G. Bone
Хэвлэсэн 2011Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Pathology
Alternative medicine
Dupilumab
Immunology
Placebo
Asthma
Gastroenterology
Adverse effect
Alemtuzumab
Randomized controlled trial
Surgery
Transplantation
Clinical trial
Denosumab
Dermatology
Incidence (geometry)
Multiple sclerosis
Optics
Osteoporosis
Physics
Atopic dermatitis
Bone mineral
Bronchodilator
Eosinophil
Nasal polyps
Pediatrics
Anesthesia
Chronic rhinosinusitis